Immunology

Compound found to trigger innate immunity against viruses

Research from UW Medicine and collaborators indicates that a drug-like molecule can activate innate immunity and induce genes to control infection in a range of RNA viruses, including West Nile, dengue, hepatitis C, influenza ...

Diseases, Conditions, Syndromes

Drug prevents passage of HBV during pregnancy

The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a study in the June issue of Clinical Gastroenterology and Hepatology, the official clinical practice journal of the ...

Diseases, Conditions, Syndromes

Cancer drug shows promise as cure for hepatitis B

Australian scientists have found a potential cure for hepatitis B virus (HBV) infections, with a promising new treatment proving 100 per cent successful in eliminating the infection in preclinical models.

Diseases, Conditions, Syndromes

Limited promise in early results from Ebola drug trial

Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed Monday it was somewhat effective at saving lives if given early in the illness, but not later.

Diseases, Conditions, Syndromes

CDC urging flu vaccination, prompt use of antivirals

(HealthDay)—Thousands of people are being hospitalized and 26 children have died from influenza so far, Tom Frieden, M.D., M.P.H., director of the U.S. Centers for Disease Control and Prevention, said during a Friday press ...

Medications

Rapivab approved to help treat flu

(HealthDay)—Rapivab (peramivir) has been approved by the U.S. Food and Drug Administration to treat influenza.

Medications

FDA approves AbbVie combo hepatitis C treatment

Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.

page 24 from 38